Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine

N Naina McCann (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) M Margarete Paganotti Vicentine (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) N Narges Ebrahimi M Melanie Greenland (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) B Brian Angus (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) A Andrea M. Collins T Thomas Darton (Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom) K Katherine Emary (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) S Saul N. Faust (NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom) A Amy Flaxman (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) N Noshi Maria (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) C Christopher A. Green (NIHR–Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom) C Claudia Juarez Molina (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) R Ravindra Paidisetti (Bharat Biotech International, Hyderabad, India) R Rajeka Lazarus (Bristol Medical School, University of Bristol, Bristol, United Kingdom) G Grace C. Macaulay (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) F Florence McLean (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) V V. Krishna Mohan (Bharat Biotech International, Hyderabad, India) M M. Gangadhara Naidu (Bharat Biotech International, Hyderabad, India) M Maheshi N. Ramasamy D D. Yogeswara Rao (Bharat Biotech International, Hyderabad, India) N Nisha Singh S Sophie Vernon (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) Y Young Chan Kim (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom) M Myron M. Levine (Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore) X Xinxue Liu A Andrew J. Pollard (Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom)

Article Details

Volume / Issue Vol. 393, Issue 17
Published October 30, 2025
Pages 1704-1714
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (27)

N

Naina McCann

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

M

Margarete Paganotti Vicentine

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

N

Narges Ebrahimi

M

Melanie Greenland

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

B

Brian Angus

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

A

Andrea M. Collins

T

Thomas Darton

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

K

Katherine Emary

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

S

Saul N. Faust

NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

A

Amy Flaxman

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

N

Noshi Maria

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

C

Christopher A. Green

NIHR–Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

C

Claudia Juarez Molina

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

R

Ravindra Paidisetti

Bharat Biotech International, Hyderabad, India

R

Rajeka Lazarus

Bristol Medical School, University of Bristol, Bristol, United Kingdom

G

Grace C. Macaulay

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

F

Florence McLean

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

V

V. Krishna Mohan

Bharat Biotech International, Hyderabad, India

M

M. Gangadhara Naidu

Bharat Biotech International, Hyderabad, India

M

Maheshi N. Ramasamy

D

D. Yogeswara Rao

Bharat Biotech International, Hyderabad, India

N

Nisha Singh

S

Sophie Vernon

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

Y

Young Chan Kim

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

M

Myron M. Levine

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore

X

Xinxue Liu

A

Andrew J. Pollard

Oxford Vaccine Group, Department of Paediatrics, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom